Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Envista Holdings Corporation is a global dental products company that designs, manufactures, and markets a broad portfolio of dental consumables, equipment, software, and specialty technologies. The company operates within the dental medical devices and technologies industry, serving dental professionals across restorative, orthodontic, implant, and diagnostic applications. Envista’s revenue is primarily driven by recurring consumables, capital equipment sales, and technology-enabled dental solutions used in routine and specialized dental care.
The company was formed through a spin-off from Danaher Corporation and became an independent publicly traded company in 2019. Since its separation, Envista has focused on building a diversified dental platform with a combination of established brands, proprietary technologies, and clinically oriented product development. Its strategy emphasizes professional trust, brand equity, and workflow integration across dental practices and laboratories.
Business Operations
Envista conducts its operations through two primary business segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment includes orthodontics, implants, and digital dentistry offerings, while the Equipment & Consumables segment provides dental consumables, imaging systems, treatment units, and infection prevention products. Revenue is generated through direct sales, distributor networks, and long-term customer relationships with dental service organizations and independent practices.
Key operating businesses and brands include Nobel Biocare, Ormco, DENTSPLY GAC, Kerr, KaVo, DEXIS, and Spark clear aligners. Envista maintains vertically integrated capabilities spanning research and development, manufacturing, and digital software platforms. The company operates manufacturing and R&D facilities globally and relies on a mix of direct sales forces and third-party distributors depending on the market.
Strategic Position & Investments
Envista’s strategic direction centers on organic growth through innovation, portfolio optimization, and expansion in higher-growth dental categories such as implants, orthodontics, and digital dentistry. The company invests in product development focused on digital workflows, diagnostics, and treatment efficiency, aiming to integrate hardware, software, and consumables into cohesive clinical solutions.
Historically, Envista has pursued selective acquisitions to strengthen its specialty and technology offerings, while also divesting non-core assets to improve operational focus. Its portfolio of subsidiaries, including Nobel Biocare and Ormco, positions the company competitively in premium segments of the global dental market. Envista continues to evaluate opportunities in emerging dental technologies, though the pace and scope of future investments depend on market conditions and capital allocation priorities.
Geographic Footprint
Envista operates on a global scale, with its corporate headquarters in the United States and significant operations across North America, Europe, and Asia-Pacific. The company sells products in over 100 countries, supported by regional sales organizations, manufacturing sites, and distribution partners. North America and Western Europe represent its largest revenue contributors, while Asia-Pacific and Latin America are viewed as longer-term growth regions.
Manufacturing, research, and commercial operations are geographically diversified to support regional demand and regulatory requirements. Envista’s international footprint allows it to participate in both mature and developing dental markets, with localized product offerings tailored to varying standards of care and economic conditions.
Leadership & Governance
Envista is led by an executive team with experience in medical devices, healthcare technology, and global operations. The company emphasizes operational discipline, customer-centric innovation, and sustainable long-term growth as core elements of its leadership philosophy.
Key executives include:
- Amir Aghdaei – President and Chief Executive Officer
- Gary Maharaj – Executive Vice President and Chief Financial Officer
- Jason Phillips – Senior Vice President, Human Resources
- Bill Ryan – Senior Vice President, Strategy and Corporate Development
Envista’s board and management oversee corporate governance, capital allocation, and strategic execution in alignment with public company standards and regulatory requirements.